Weekly Rundown: Small-Cap Stocks with Upcoming Catalysts (May 19–23)

We've reviewed the latest filings and corporate updates to highlight the most noteworthy small-cap developments and investor events happening this week. Our aim is to keep you ahead of the curve with timely insights into emerging opportunities. Here’s what’s on our radar for the week of May 19 to May 23.

Companies presenting at the 3rd Annual H.C. Wainwright BioConnect Investor Conference (May 20, 2025, New York, NY):

LXRX PLX LCTX SVRA DMAC NUVB

------------------------------------------------------------------

AMLX OLMA PHAT DRTS OABI NBTX

------------------------------------------------------------------

SCPH NKTR ALEC OBIO IVVD ESPR

------------------------------------------------------------------

OPK TARA AKBA RZLT ANIX HURA

Companies that will be participating in the Ladenburg Thalmann Innovation EXPO25, to be held in New York City on Wednesday, May 21, 2025:

ARBE INUV PRSO USIO IDN BLNE

-------------------------------------------------------------------

BMR PAYS NOTE ZENA CREX FCUV

Companies that will participate in a fireside chat at the A.G.P. Healthcare Company Showcase, taking place virtually May 21, 2025.:

ACXP RNXT LPCN GRI RVPH

Companies that will present and host one-on-one meetings with investors at the Sidoti Micro-Cap Virtual Investor Conference, taking place on May 21-22, 2025.:

TNMG GSIT IVP FEAM FTEK CPSH

------------------------------------------------------------------

ASBP MNDR HTCR EVAX

Companies presenting at TIDES USA 2025, May 19–22, 2025, Manchester Grand Hyatt San Diego:

MGX > Oral Presentation: AI-Guided Metagenomic Discovery of Compact CRISPR Systems for In Vivo Therapeutic Genome Editing (Thursday, May 22, 2025)

CDXS > TIDES Talk: Comparative Analysis of Diastereomeric Distribution in siRNA Synthesis: Phosphoramidite Chemistry vs. Enzymatic Synthesis (Wednesday, May 21, 2025)

PRQR > Title: Advancing Axiomer ADAR RNA Editing Platform - Editing Oligonucleotides Optimization for Therapeutic Use (May 22, 2025)

EDIT > Present preclinical data and participate in panel presentations on Oligonucleotide & Peptide Therapeutics (May 19–22, 2025)

Companies participating at XPONENTIAL 2025, taking place May 19–22, 2025, at the George R. Brown Convention Center in Houston:

PRZO ZENA MOB AMPX

Companies that will participate at the B. Riley Securities 25th Annual Institutional Investor Conference, May 21–22, 2025:

WULF RBBN TOI PHLT TBLA BRLT

Companies that will participate in a fireside chat during the 2025 RBC Capital Markets Healthcare Conference on May 20–21, 2025:

CMPS CATX CTNM MNKD CYTK PYXS

---------------------------------------------------------------------------

ADCT JSPR SERA DSGN DMAC FDMT

---------------------------------------------------------------------------

AVAH NUVB

Companies presenting at the 2025 American Thoracic Society (ATS) International Conference, from May 16–21, 2025:

RNTX > Oral Presentation: Evaluating Alveolar Regenerative Properties of Caveolin Scaffolding Peptides (CSD) in Three Dimensional (3D) Alveolospheres from IPF and Normal Donor Lung Samples (Monday, May 19, 2025)

BDSX > Oral Presentation: Utilization of Proteomic Testing in Pulmonary Nodule Risk Stratification at a Safety-Net Hospital: An Observational Study (Monday, May 19, 2025)

ATYR > Poster 6808: EFZO-FIT, Largest Placebo-Controlled Trial in Pulmonary Sarcoidosis – Trial Design and Patient Characteristics (Monday, May 19, 2025) Poster 9092: Incidence, Prevalence, and Mortality of Pulmonary Sarcoidosis with Parenchymal Involvement in the US (Tuesday, May 20, 2025)

SVRA > Oral Presentation: Advances in Autoimmune Pulmonary Alveolar Proteinosis (Tuesday, May 20, 2025)

PLRX > Scientific Posters: Company to present three scientific posters (May 19 and 21, 2025)

GRI > Oral Presentation: Inactivation of iNKT Cells After the Inflammatory Phase Leads to Significant Inhibition of Fibroblast Activation and Fibrosis in a Model of Pulmonary Fibrosis (Wednesday, May 21, 2025)

Other companies with key Catalysts this week:

VNDA > Will participate in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025.

FTHM > Invite investors to a webinar on May 20, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Fathom's CEO, Marco Fregenal.

RR > Expanding capabilities of its AI-powered barista robot with a new artisanal espresso system debuting at the National Restaurant Association Show, McCormick Place Convention Center, Chicago (May 17–20, 2025).

HOUS > Chief Executive Officer and President Ryan Schneider will participate in the KBW Virtual Real Estate Finance & Technology Conference on Tuesday, May 20, 2025.

CIFR > Barclays 15th Annual Emerging Payments and FinTech Forum Monday, May 19th, 2025.

MCRP > Management team is scheduled to present at the Aegis Capital Corp. 2025 Virtual Conference on May 20, 2025.

DVLT > The Company expects to close its acquisition of CompuSystems, Inc. (CSI) during the week of May 19, 2025.

NVTS > Will host an "AI Tech Night" event in Taipei, Taiwan, gathering industry experts, supply chain partners, and technology developers for keynote speeches, demos, and interactive discussions (May 21, 2025, 6:30 PM–9:00 PM).

ICG > Will be attending The Benchmark Company's first iteration of their Virtual Digital Assets Seminar on Tuesday, May 20th EDT.

DMAC > Poster presentation of the safety and clinical outcomes for ReMEDy2 study, the planned pivotal phase 2/3 trial of DM199 in AIS patients, at the 11th European Stroke Organisation Conference – ESOC 2025 being held in Helsinki, Finland from May 21-23, 2025.

DYAI > Will participate in the inaugural European Vaccines Hub for Pandemic Readiness ("EVH") meeting on May 22–23, 2025.

AMIX > Will participate in the Virtual Investor Closing Bell Series on Thursday, May 22, 2025 at 4:00 PM ET.

ONFO > Interactive presentation at the Emerging Growth Conference on May 22, 2025.

OSUR > Targeted Genomics and DNA Genotek, the subsidiary of OraSure Technologies that makes the ORAcollect®·Dx saliva collection device, have scheduled a joint webinar entitled "Insights from the development of a U.S. FDA cleared genetic health risk test" on May 21, 2025 at 1 p.m. EST.

RYAM > Will participate in a fireside chat with coverage analyst Dmitry Silversteyn from Water Tower Research on Wednesday, May 21, 2025.

UNIT > Scheduled to participate at the Barclays 2025 Leveraged Finance Conference on May 20, 2025 in Austin, TX.

FTCI > CLEANPOWER 2025 – May 20, 2025, Phoenix. The company will participate in group investor meetings with analysts from UBS, Guggenheim, and Roth Securities.

ALXO > Will host a webcast event on May 20, 2025, to provide an update on ALX2004, the Company's potentially best- and first-in-class investigational antibody-drug conjugate (ADC).

NFGC > Keith Boyle (CEO) and Fiona Childe (VP Communications & Corporate Development) will attend the Canaccord Genuity Conference in Henderson, NV (May 20–22, 2025), participating in one-on-one investor meetings. Mr. Boyle will speak on the Advanced Exploration/Early-Stage Developers Panel at 10:45 AM on May 22 in Casablanca Ballroom F/G.

NAOV > Findings from a recent retrospective case series evaluating the clinical impact and patient experience of the UroShield™ system. The case series will be presented on May 19, 2025, at the Association for Continence Professionals annual conference (ACP 2025).

OGEN > Will host a management update webinar on Tuesday, May 20, 2025 at 4:00 PM ET to discuss the growing unmet medical need in concussion treatment and provide an overview of its lead program, ONP-002, a proprietary neuroprotective therapy designed for the treatment of mild traumatic brain injury (mTBI), also known as concussion.

BNRG > Publication of a joint case study with the New York Power Authority (NYPA) detailing the deployment and performance of a TES system at Purchase College, State University of New York (SUNY). The project and its key findings will be presented in a webinar hosted by the Renewable Thermal Collaborative on Monday, May 19, 2025, at 11:00 AM EDT / 8:00 AM PDT.

FMTO > Will present at the upcoming Aegis Capital Financial Conference to be held on May 20-22, 2025.

ANNX > Real-World Evidence study to be featured in an oral presentation on Monday May 19, 2025 at the upcoming 2025 Peripheral Nerve Society (PNS) Annual Meeting.

ARTV > Preclinical data on the ablation of SLE donor B-cells with AlloNK in combination with either an anti-CD19 or anti-CD20 monoclonal antibody presented at the 2025 Pan-American League of Rheumatology Congress (PANLAR) and to be presented at the 16th International Congress on Systemic Lupus Erythematosus (LUPUS 2025), being held May 21-24, 2025, in Toronto, Canada.

PERF > Perfect Corp. will host an exclusive Beautiful AI Luncheon at the New York Stock Exchange on May 20th, 2025.

RSKD > Barclays 15th Annual Emerging Payments and FinTech Forum in New York on Tuesday, May 20th, at 1:50 PM ET.

GRO > CG Global Metals & Mining Conference - May 20-22, 2025 in Henderson, NV.

CHRS > HCW BioConnect @ Nasdaq NYC 2025 in New York, NY on Tuesday, May 20, 2025.

INV > Will sponsor The Front End of Innovation 2025 will take place on May 19-21.

ICAD > Will showcase this next-generation AI collaboration, along with its end-to-end breast health AI suite and the recently cleared ProFound Detection Version 4.0, at the upcoming 2025 SIIM25 Annual Meeting + InformaticsTECH Expo in Portland, OR from May 21st to May 23rd.

CMND > Live webinar titled "Gazing Through the Crystal Ball." The event is scheduled for May 21, 2025, at 12:00 PM ET (9:00 AM PT) and will feature a distinguished panel of experts discussing the evolving landscape of psychedelic science and business in the context of changing FDA policies and political climates.

CIA > Singular Research will host a fireside chat webcast with Citizens management on May 22 at 2:00 ET, moderated by a Singular Research analyst.

LMFA > May 20, 2025: Benchmark Virtual Digital Asset Seminar.

MVIS > MicroVision's Retail Investor Day in Redmond, Washington on Tuesday, May 20, 2025.

GCL > The new release date for the highly anticipated “JDM: Japanese Drift Master” is scheduled to be released on Steam, GoG, and Epic Store on May 21, 2025.

KAPA > May 20 to June 5 – The American Society of Clinical Oncology (ASCO) has accepted an abstract to be presented at its Annual Meeting in Chicago.

WINT > Entered into an Assignment and Conditional Assumption Agreement with a seasoned real estate investment group to acquire a 436-unit multifamily residential property in Houston, Texas. The acquisition is expected to generate stable rental income while the Company advances its therapeutic pipeline. The purchase will be made through a wholly owned subsidiary, with anticipated new management. Funding will primarily come from non-recourse secured mortgage financing, with the remaining balance covered by proceeds from the issuance of preferred stock. The acquisition is contingent upon standard due diligence and final financing terms. The initial closing is targeted for May 23, 2025, with two optional 30-day extension periods.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.